1
Clinical Trials associated with Oryz-Aspergillus Enzyme And Pancreatin / Unknown statusNot Applicable A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Study to Evaluate the Safety and Efficacy of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Improving Malnutrition in Patients With Cirrhosis
The investigation is a randomized, double-blind, placebo involved and multi-center clinical trial. All subjects are assigned to 2 groups, including Oryz-Aspergillus Enzyme and Pancreatin tablet group (treatment group) and the placebo group (control group). Treatment group includes 99 subjects, while control group includes 33 subjects. They receive investigational drug 2 tablets/times, tid, p.o. for 180 days.
100 Clinical Results associated with Oryz-Aspergillus Enzyme And Pancreatin
100 Translational Medicine associated with Oryz-Aspergillus Enzyme And Pancreatin
100 Patents (Medical) associated with Oryz-Aspergillus Enzyme And Pancreatin
100 Deals associated with Oryz-Aspergillus Enzyme And Pancreatin